Found 15 matching trials
Ibudilast for the Treatment of Alcohol Use Disorder
PHASE2This study is a double-blind, placebo-controlled randomized clinical trial ...
Location
UCLA Addictions Laboratory
Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)
PHASE2This is a single center, randomized, double-blind, placebo-controlled, 6-mo...
Location
Carolinas Healthcare System, Dept. of Neurology
Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS
PHASE2The goal of this study is to evaluate the effects of Ibudilast (MN-166) ver...
Location
Denver Health and Hospital Authority
Ibudilast in the Treatment of Medication Overuse Headache
PHASE1The purpose of this study is to determine if ibudilast is effective in reve...
Location
Pain and Anaesthesia Research Clinic, Royal Adelaide Hospital
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
PHASE2A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, par...
Status
Active Not Recruiting
Location
University of California
Regeneration in Cervical Degenerative Myelopathy
PHASE3Degenerative (wear and tear arthritis of the spine) Cervical (concerning th...
Location
Addenbrooke's Hospital
Ibudilast in the Treatment of Patients With Chronic Migraine.
PHASE1This will be a double-blind, randomised, placebo-controlled, two period cro...
Location
School of Medical sciences, University of Adelaide
Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users
PHASE2Addiction to methamphetamine is a serious health problem in the United Stat...
Location
VA Portland Health Care System, Portland, OR
Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers
PHASE2Opioid drugs increase glial cell activation which may be related to the abu...
Location
New York State Psychiatric Institute
Development of Ibudilast for Alcohol Use Disorder
PHASE1The objective of this proposal is to advance medication development for alc...
Location
UCLA Addictions Laboratory